Laxai Pharma (OTCPK:LAXA.F) - Stock Price, News & Analysis

LAXA.F Stock Overview

Laxai Pharma, Ltd. offers contract research services in the United States.

LAXA.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Does not have a meaningful market cap ($7K)

Shares are highly illiquid

Latest financial reports are more than a year old

Laxai Pharma, Ltd. Competitors

Genocea Biosciences

OTCPK:GNCA.Q

US$5.9k

MJ Holdings

OTCPK:MJNE

US$5.8k

ObsEva

OTCPK:OBSE.F

US$11.7k

DermTech

OTCPK:DMTK.Q

US$3.5k

Price History & Performance

Summary of all time highs, changes and price drops for Laxai Pharma
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
33 Year Change	-98.89%
5 Year Change	-93.33%
Change since IPO	-99.99%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	LAXA.F	US Life Sciences	US Market
7D	0%	2.2%	-1.6%
1Y	0%	17.9%	30.8%

Return vs Industry: LAXA.F exceeded the US Life Sciences industry which returned -12.6% over the past year.

Return vs Market: LAXA.F underperformed the US Market which returned 15.2% over the past year.

Price Volatility

Is LAXA.F's price volatile compared to industry and market?
LAXA.F volatility
LAXA.F Average Weekly Movement	n/a
Life Sciences Industry Average Movement	7.8%
Market Average Movement	6.0%
10% most volatile stocks in US Market	14.9%
10% least volatile stocks in US Market	2.9%

Stable Share Price: LAXA.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine LAXA.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	n/a

Laxai Pharma, Ltd. offers contract research services in the United States. It provides integrated services across the drug development spectrum. The company focuses its services in the areas of biostatistics, data management (EDC, Hybrid, and Paper), CDISC consulting, medical writing, monitoring, regulatory, drug safety, and related training programs.

Laxai Pharma, Ltd. Fundamentals Summary

How do Laxai Pharma's earnings and revenue compare to its market cap?
LAXA.F fundamental statistics
Market cap	US$6.67k
Earnings (TTM)	-US$1.91m
Revenue (TTM)	US$3.06m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is LAXA.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LAXA.F income statement (TTM)
Revenue	US$3.06m
Cost of Revenue	US$2.38m
Gross Profit	US$676.00k
Other Expenses	US$2.58m
Earnings	-US$1.91m

Last Reported Earnings

Sep 30, 2010

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did LAXA.F perform over the long term?

See historical performance and comparison